The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China

BACKGROUND: Despite recent advances through the development pipeline, how novel tuberculosis (TB) vaccines might affect rifampicin-resistant and multidrug-resistant tuberculosis (RR/MDR-TB) is unknown. We investigated the epidemiologic impact, cost-effectiveness, and budget impact of hypothetical no...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Med
Main Authors: Weerasuriya, Chathika K, Harris, Rebecca C, McQuaid, C Finn, Bozzani, Fiammetta, Ruan, Yunzhou, Li, Renzhong, Li, Tao, Rade, Kirankumar, Rao, Raghuram, Ginsberg, Ann M, Gomez, Gabriela B, White, Richard G
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7908776/
https://ncbi.nlm.nih.gov/pubmed/33632218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-021-01932-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados